117 related articles for article (PubMed ID: 23836040)
1. Perspectives on human clinical trials of therapies using iPS cells in Japan: reaching the forefront of stem-cell therapies.
Song P; Inagaki Y; Sugawara Y; Kokudo N
Biosci Trends; 2013 Jun; 7(3):157-8. PubMed ID: 23836040
[TBL] [Abstract][Full Text] [Related]
2. [Development of novel therapies using human iPS cell-derived retinal pigment epithelia].
Arakawa D; Ito A; Osakada F
Nihon Yakurigaku Zasshi; 2016; 148(4):217. PubMed ID: 27725570
[No Abstract] [Full Text] [Related]
3. [Retinal regeneration with iPS cells ‒ Clinical trials for retinal degenerative disorders].
Sugita S
Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(2):79-85. PubMed ID: 26016634
[TBL] [Abstract][Full Text] [Related]
4. Fabricating retinal pigment epithelial cell sheets derived from human induced pluripotent stem cells in an automated closed culture system for regenerative medicine.
Matsumoto E; Koide N; Hanzawa H; Kiyama M; Ohta M; Kuwabara J; Takeda S; Takahashi M
PLoS One; 2019; 14(3):e0212369. PubMed ID: 30865653
[TBL] [Abstract][Full Text] [Related]
5. What's old is new again: Autologous stem cell transplant for AMD.
Byrne LC
Sci Transl Med; 2017 Apr; 9(387):. PubMed ID: 28446683
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of human pluripotent stem cells to retinal pigmented epithelium in defined conditions using purified extracellular matrix proteins.
Rowland TJ; Blaschke AJ; Buchholz DE; Hikita ST; Johnson LV; Clegg DO
J Tissue Eng Regen Med; 2013 Aug; 7(8):642-53. PubMed ID: 22514096
[TBL] [Abstract][Full Text] [Related]
7. Stem Cell Treatment for Age-Related Macular Degeneration: the Challenges.
Singh MS; MacLaren RE
Invest Ophthalmol Vis Sci; 2018 Mar; 59(4):AMD78-AMD82. PubMed ID: 30025109
[No Abstract] [Full Text] [Related]
8. Concise Review: Making Stem Cells Retinal: Methods for Deriving Retinal Pigment Epithelium and Implications for Patients With Ocular Disease.
Leach LL; Clegg DO
Stem Cells; 2015 Aug; 33(8):2363-73. PubMed ID: 25809736
[TBL] [Abstract][Full Text] [Related]
9. Cell-Based Therapy for Degenerative Retinal Disease.
Zarbin M
Trends Mol Med; 2016 Feb; 22(2):115-134. PubMed ID: 26791247
[TBL] [Abstract][Full Text] [Related]
10. Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration.
Mandai M; Watanabe A; Kurimoto Y; Hirami Y; Morinaga C; Daimon T; Fujihara M; Akimaru H; Sakai N; Shibata Y; Terada M; Nomiya Y; Tanishima S; Nakamura M; Kamao H; Sugita S; Onishi A; Ito T; Fujita K; Kawamata S; Go MJ; Shinohara C; Hata KI; Sawada M; Yamamoto M; Ohta S; Ohara Y; Yoshida K; Kuwahara J; Kitano Y; Amano N; Umekage M; Kitaoka F; Tanaka A; Okada C; Takasu N; Ogawa S; Yamanaka S; Takahashi M
N Engl J Med; 2017 Mar; 376(11):1038-1046. PubMed ID: 28296613
[TBL] [Abstract][Full Text] [Related]
11. [Retinal cell therapy using iPS cells].
Takahashi M
Rinsho Shinkeigaku; 2013; 53(11):1016. PubMed ID: 24291864
[No Abstract] [Full Text] [Related]
12. Memory in induced pluripotent stem cells: reprogrammed human retinal-pigmented epithelial cells show tendency for spontaneous redifferentiation.
Hu Q; Friedrich AM; Johnson LV; Clegg DO
Stem Cells; 2010 Nov; 28(11):1981-91. PubMed ID: 20882530
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA expression profiles of human iPS cells, retinal pigment epithelium derived from iPS, and fetal retinal pigment epithelium.
Greene WA; Muñiz A; Plamper ML; Kaini RR; Wang HC
J Vis Exp; 2014 Jun; (88):e51589. PubMed ID: 24999033
[TBL] [Abstract][Full Text] [Related]
14. Personalized Medicine: Cell and Gene Therapy Based on Patient-Specific iPSC-Derived Retinal Pigment Epithelium Cells.
Li Y; Chan L; Nguyen HV; Tsang SH
Adv Exp Med Biol; 2016; 854():549-55. PubMed ID: 26427458
[TBL] [Abstract][Full Text] [Related]
15. Stem cells in retinal regeneration: past, present and future.
Ramsden CM; Powner MB; Carr AJ; Smart MJ; da Cruz L; Coffey PJ
Development; 2013 Jun; 140(12):2576-85. PubMed ID: 23715550
[TBL] [Abstract][Full Text] [Related]
16. Induced pluripotent stem cell therapies for geographic atrophy of age-related macular degeneration.
Du H; Lim SL; Grob S; Zhang K
Semin Ophthalmol; 2011 May; 26(3):216-24. PubMed ID: 21609235
[TBL] [Abstract][Full Text] [Related]
17. Japan stem-cell trial stirs envy.
Reardon S; Cyranoski D
Nature; 2014 Sep; 513(7518):287-8. PubMed ID: 25230622
[No Abstract] [Full Text] [Related]
18. Induced pluripotent stem cells generate both retinal ganglion cells and photoreceptors: therapeutic implications in degenerative changes in glaucoma and age-related macular degeneration.
Parameswaran S; Balasubramanian S; Babai N; Qiu F; Eudy JD; Thoreson WB; Ahmad I
Stem Cells; 2010 Apr; 28(4):695-703. PubMed ID: 20166150
[TBL] [Abstract][Full Text] [Related]
19. NIH stem-cell programme closes.
Reardon S
Nature; 2014 Apr; 508(7495):157. PubMed ID: 24717485
[No Abstract] [Full Text] [Related]
20. Induction of retinal pigment epithelial cells from monkey iPS cells.
Okamoto S; Takahashi M
Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8785-90. PubMed ID: 21896853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
